MoneyWorks4Me

Indoco Remedies informs about analyst meet

19 Jul 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it enclosed a schedule of Analyst / Investor Meeting to be held on August 12, 2022. The schedule of aforesaid Meetings is subject to change due to exigencies on the part of Investor/Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..